The effect of three dose levels of ICS 205-930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomiting.
Seinen
H
H
Department of Oncology, Utrecht University Hospital, The Netherlands.
Zonnenberg
B A
BA
Tjia
P
P
Neijt
J P
JP
D000328:Adult; D000368:Aged; D002945:Cisplatin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007211:Indoles; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000077526:Tropisetron; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D007211:Indoles; D012702:Serotonin Antagonists; D000077526:Tropisetron; D002945:Cisplatin